Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00380523Phase 4Completed
Phase 4, open-label, single-arm trial of etoricoxib in acute pain, sponsored by Organon & Co. Primary endpoint: Verbal Analog Scale Pain Score at 3 days. Started Apr 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00380523.